| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Juan D Duque-Yemail, Juan Carlos Avil. Switching Clozapine to Cariprazine in Three Patients with Persistent Symptoms of Schizophrenia: A Case Series. Neuropsychiatric disease and treatment. vol 18. 2022-07-21. PMID:35859803. |
clozapine has shown efficacy in treating schizophrenia patients who failed to respond to previous antipsychotics. |
2022-07-21 |
2023-08-14 |
Not clear |
| Marte Z van der Horst, Georgia Papadimitriou, Jurjen J Luyk. Genetic determinants associated with response to clozapine in schizophrenia: an umbrella review. Psychiatric genetics. 2022-07-20. PMID:35855515. |
genetic determinants associated with response to clozapine in schizophrenia: an umbrella review. |
2022-07-20 |
2023-08-14 |
Not clear |
| Erica Neill, Susan L Rossell, Caitlin Yolland, Denny Meyer, Cherrie Galletly, Anthony Harris, Dan Siskind, Michael Berk, Kiymet Bozaoglu, Frances Dark, Olivia M Dean, Paul S Francis, Dennis Liu, Andrea Phillipou, Jerome Sarris, David J Castl. N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms. Schizophrenia bulletin. 2022-07-20. PMID:35857752. |
n-acetylcysteine (nac) in schizophrenia resistant to clozapine: a double-blind, randomized, placebo-controlled trial targeting negative symptoms. |
2022-07-20 |
2023-08-14 |
Not clear |
| Estela Sangüesa, Christine Cirujeda, Julia Concha, Pedro Pablo Padilla, Cristina Belén García, María Pilar Ribat. Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions? Chemico-biological interactions. 2022-07-19. PMID:35853541. |
pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: does ugt polymorphism affect these drug interactions? |
2022-07-19 |
2023-08-14 |
Not clear |
| Estela Sangüesa, Christine Cirujeda, Julia Concha, Pedro Pablo Padilla, Cristina Belén García, María Pilar Ribat. Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions? Chemico-biological interactions. 2022-07-19. PMID:35853541. |
the combination of valproic acid (vpa) and clozapine (clz) is regularly prescribed for augmentation therapy in treatment resistant schizophrenia. |
2022-07-19 |
2023-08-14 |
Not clear |
| Sukhpreet Poonia, Mazen Sharaf, Ric M Procyshyn, Randal White, Reza Rafizade. Amisulpride Augmentation of Clozapine in Clozapine-Resistant Schizophrenia: A Case Series. The Canadian journal of hospital pharmacy. vol 75. issue 3. 2022-07-18. PMID:35847467. |
amisulpride augmentation of clozapine in clozapine-resistant schizophrenia: a case series. |
2022-07-18 |
2023-08-14 |
Not clear |
| Nicole M McGrath, Verity Humberstone, Ashley C Abraha. Diabetes mellitus prevalence in Northland New Zealand schizophrenia patients on clozapine. The New Zealand medical journal. vol 135. issue 1558. 2022-07-14. PMID:35834832. |
diabetes mellitus prevalence in northland new zealand schizophrenia patients on clozapine. |
2022-07-14 |
2023-08-14 |
Not clear |
| Nicole M McGrath, Verity Humberstone, Ashley C Abraha. Diabetes mellitus prevalence in Northland New Zealand schizophrenia patients on clozapine. The New Zealand medical journal. vol 135. issue 1558. 2022-07-14. PMID:35834832. |
clozapine is a unique atypical anti-psychotic agent with best efficacy for treatment resistant schizophrenia compared to other agents, but with increased metabolic adverse effects. |
2022-07-14 |
2023-08-14 |
Not clear |
| Hirofumi Hirakawa, Takeshi Terao, Masaaki Muronag. Successful treatment using combined monthly maintenance electroconvulsive therapy and monthly long-acting injection paliperidone for treatment-resistant schizophrenia with vulnerability to clozapine: a case report. Psychiatry and clinical neurosciences. 2022-07-13. PMID:35822460. |
successful treatment using combined monthly maintenance electroconvulsive therapy and monthly long-acting injection paliperidone for treatment-resistant schizophrenia with vulnerability to clozapine: a case report. |
2022-07-13 |
2023-08-14 |
Not clear |
| Georgios Schoretsanitis, Jose de Leo. Best Practices for Starting Clozapine in Patients With Schizophrenia: How to Switch From the Prior Antipsychotic(s). The Journal of clinical psychiatry. vol 83. issue 4. 2022-07-08. PMID:35802932. |
best practices for starting clozapine in patients with schizophrenia: how to switch from the prior antipsychotic(s). |
2022-07-08 |
2023-08-14 |
Not clear |
| Amarpreet Singh, Darci Delgado, Maria I Ventura, Eric Schwartz, Jared Williams, Jonathan M Meye. Clozapine Use and Forensic Outcomes in Psychiatric Inpatients Deemed Incompetent to Stand Trial. The journal of the American Academy of Psychiatry and the Law. 2022-07-07. PMID:35798392. |
there were 191 new clozapine starts among ist patients, 92.7 percent of whom were diagnosed with schizophrenia or another psychosis. |
2022-07-07 |
2023-08-14 |
Not clear |
| Evyn Peters, Arash Shamloo, Rohit J Lodhi, Gene Marcoux, Kylie Jackson, Shawn Halayka, Lloyd Balbuen. Medication Gaps and Antipsychotic Polypharmacy in Previously Hospitalized Schizophrenia Patients: An Electronic Cohort Study in Three Canadian Provinces. Frontiers in psychiatry. vol 13. 2022-07-05. PMID:35782434. |
we aimed to calculate the cumulative time spent in second generation antipsychotics (sgas), gaps, antipsychotic polypharmacy, and clozapine in discharged schizophrenia patients. |
2022-07-05 |
2023-08-14 |
Not clear |
| Anita Margarette Bayya Ventura, Richard D Hayes, Daniela Fonseca de Freita. Ethnic disparities in clozapine prescription for service-users with schizophrenia-spectrum disorders: a systematic review. Psychological medicine. 2022-07-05. PMID:35787301. |
clozapine is the only licenced medication for treating treatment-resistant schizophrenia. |
2022-07-05 |
2023-08-14 |
Not clear |
| Anita Margarette Bayya Ventura, Richard D Hayes, Daniela Fonseca de Freita. Ethnic disparities in clozapine prescription for service-users with schizophrenia-spectrum disorders: a systematic review. Psychological medicine. 2022-07-05. PMID:35787301. |
we searched cinahl, pubmed, medline, embase, apa psycinfo and open grey and reviewed studies reporting on the proportion of service-users prescribed clozapine separately for different ethnic groups, in individuals with a primary diagnosis of schizophrenia or any schizophrenia-spectrum disorders. |
2022-07-05 |
2023-08-14 |
Not clear |
| Sandeep Grover, Chandrima Naskar, Subho Chakrabart. Factors Associated With Poor Response to Clozapine in Schizophrenia: A Study From Northern India. Journal of clinical psychopharmacology. vol 42. issue 4. 2022-06-28. PMID:35763756. |
factors associated with poor response to clozapine in schizophrenia: a study from northern india. |
2022-06-28 |
2023-08-14 |
Not clear |
| Sandeep Grover, Chandrima Naskar, Subho Chakrabart. Factors Associated With Poor Response to Clozapine in Schizophrenia: A Study From Northern India. Journal of clinical psychopharmacology. vol 42. issue 4. 2022-06-28. PMID:35763756. |
this study aimed to assess the demographic and clinical factors associated with an inadequate response to clozapine in patients with treatment-resistant schizophrenia (trs). |
2022-06-28 |
2023-08-14 |
Not clear |
| Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, Mirko Manchia, Vincenzo De Luca, Felice Iasevoli, Christoph U Correl. Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia. Pharmacology & therapeutics. 2022-06-28. PMID:35764175. |
almost fifty years after its first introduction into clinical care, clozapine remains the only evidence-based pharmacological option for treatment-resistant schizophrenia (trs), which affects approximately 30% of patients with schizophrenia. |
2022-06-28 |
2023-08-14 |
Not clear |
| C U Correll, Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, Andrea Fagiolini, Niko Seppälä, Oliver D Howe. A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia. CNS drugs. 2022-06-27. PMID:35759211. |
a guideline and checklist for initiating and managing clozapine treatment in patients with treatment-resistant schizophrenia. |
2022-06-27 |
2023-08-14 |
Not clear |
| Yue Feng Quek, Yuen Mei See, Jie Yin Yee, Gurpreet Rekhi, Boon Tat Ng, Charmaine Tang, Jimmy Le. Metabolic syndrome and cardiovascular risk between clozapine and non-clozapine antipsychotic users with schizophrenia. Asian journal of psychiatry. vol 74. 2022-06-25. PMID:35751958. |
metabolic syndrome and cardiovascular risk between clozapine and non-clozapine antipsychotic users with schizophrenia. |
2022-06-25 |
2023-08-14 |
Not clear |
| Yue Feng Quek, Yuen Mei See, Jie Yin Yee, Gurpreet Rekhi, Boon Tat Ng, Charmaine Tang, Jimmy Le. Metabolic syndrome and cardiovascular risk between clozapine and non-clozapine antipsychotic users with schizophrenia. Asian journal of psychiatry. vol 74. 2022-06-25. PMID:35751958. |
thus, this study aims to establish and compare the cardiometabolic profiles between non-clozapine antipsychotic and clozapine users with schizophrenia. |
2022-06-25 |
2023-08-14 |
Not clear |